VTRSNasdaqSEC EDGAREDGAR

Viatris Inc

Pharmaceutical Preparations·CANONSBURG, PA·FY end 12/31·CIK 1792044

Board of Directors

13 members · 12 independent · FY 2025
DirectorRoleTenureAgeCommitteesIndep.Annual fees
W. Don CornwellDirector5y78AuditRiskGovernance and Sustainability—
Frank D'AmelioDirector0y68CompFinance—
JoEllen Lyons DillonDirector5y62AuditCompExecutiveGovernance and Sustainability—
Elisha FinneyDirector3y64AuditFinance—
Leo GroothuisDirector2y53RiskExecutiveGovernance and Sustainability—
Melina HigginsChair5y58ExecutiveFinance—
James M. KiltsDirector5y78CompFinance—
Richard MarkDirector5y72AuditRiskExecutiveFinance—
Mark ParrishDirector5y70RiskExecutiveGovernance and SustainabilityTech—
Michael Severino, M.D.Director0y60AuditTech—
David SimmonsDirector0y61CompTech—
Scott A. SmithCEO and Director3y63Tech——
Rogério Vivaldi Coelho, M.D.Director1y62RiskTech—

Risk-factor diff

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Policies & disclosures

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.